Results 131 to 140 of about 154,598 (309)
Fangchinoline is identified as a small‐molecule DNGR‐1 modulator that enhances dendritic‐cell cross‐presentation of tumor antigens. By engaging DNGR‐1 and activating Syk–Nox2 signaling, it promotes phagosomal ROS, antigen escape, MHC‐I presentation, and CD8+ T‐cell priming, thereby strengthening antitumor immunity and sensitizing tumors to PD‐1 ...
Yuan Liao +19 more
wiley +1 more source
Patient PBMC differentiation to macrophages v1
Patient PBMC differentiation to macrophages
openaire +1 more source
EGFP expression in PBMCs infected with H6R28LEP.
PBMCs were infected with H6R28LEP by using the centrifuge method and then were observed under polarizing microscopy (left) and fluorescent microscopy (right) at 4 d after infection.
Tadao Tanaka (104452) +6 more
core +1 more source
Expanded NCAM1+EpCAM+ hepatic progenitor cells in biliary atresia are characterized by aggregation of α‐synuclein. This pathological protein potentiates cellular susceptibility to GSH‐dependent redox dyshomeostasis, induces unstable biliary cell fate specification, and subsequently drives aberrant biliary regeneration.
Hua Xie +12 more
wiley +1 more source
Viral mRNA and protein expression in H6R28LEP-infected PBMCs.
A: PBMCs and CMBCs were infected with H6R28LEP, total RNA was purified after 24 h, and mRNA expression of immediate early (U90, U94), early (U41, U69), and late (U24, U39, U48) genes was assayed by real-time PCR after RT.
Tadao Tanaka (104452) +6 more
core +1 more source
Placental Site Trophoblastic Tumor Acquires Immune Functions by Incorporating Host Maternal Genes
PSTT cells, through cell fusion with B cells, incorporate abundant non‐inherited maternal genes that are detectable by DNIMA. These hybrid cells acquire immunotherapy‐resistant genetic changes and increase the expression of B cell‐derived immune‐related molecules such as Ig, HLA, LILRB, SIGLEC10, and so on, creating an immunotolerant environment around
Kyosuke Kagami +15 more
wiley +1 more source
CCR2+ PBMCs in ALS patients with varying clinical characteristics.
(A) Percentage (%) of PBMCs expressing CCR2 protein in ALS patients with mild, moderate and severe neurological impairments as indicated by ALSFRS-R. (B) Count (%) of CCR2+ PBMCs in ALS subjects with disease duration (DD) ≤19 months and DD>19 months. (C)
Akshay Anand (118579) +3 more
core +1 more source
Single‐cell RNA editing analysis identifies ADAR1 as a regulator of dysfunctional T cell states in colorectal cancer. Elevated ADAR1 activity promotes T cell exhaustion and impairs antitumor immunity partly through TGF‐β‐SMAD signaling, contributing to anti‐PD‐1 resistance and highlighting T cell ADAR1 as a potential therapeutic target and biomarker ...
Da Kang +10 more
wiley +1 more source
CITE-Seq PBMCs with demultiplexing v1
Total-Seq labelling with demultiplexing This protocol reflects a common experimental design where PBMC samples from multiple human donors are pooled together for Total-Seq (CITE-Seq) labelling. Often multiple samples from the same donor are to be profiled. An example is timepoint or treatment. Therefore we utilise 2 levels of multiplexing The distinct
openaire +1 more source
Inhibition of KDELR2 in a small fraction of tumor cells generates sustainable immunogenic cell death conditions within the tumor microenvironment. These conditions promote the regression of tumors in a T cell independent manner. During regression, macrophages prime T cells that subsequently provide systemic protection against recurrence. The potency of
Shakti P Pattanayak +6 more
wiley +1 more source

